Results 281 to 290 of about 139,220 (339)

Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial. [PDF]

J Hypertens
Peeters LEJ, Kappers MHW, Hesselink DA, van der Net JB, Hartong SCC, van de Laar R, Ezzahti M, van de Ven PJG, van der Meer IM, de Bruijne ELE, Kroon AA, Indhirajanti-Tomasoa S, van der Linde NAJ, Bahmany S, Boersma E, Massey EK, van Dijk L, van Gelder T, Koch BCP, Versmissen J.   +19 more
europepmc   +1 more source

The risk of myocardial infarction associated with antihypertensive drug therapies

, 1996

openalex   +2 more sources

Aging China's cardiac challenge: Projected growth of atrial arrhythmia cases and healthcare preparedness through 2045 — A global burden disease analysis

Geriatrics &Gerontology International, EarlyView.
Atrial fibrillation/flutter cases in China have tripled since 1990. Using GBD 2021 data and BAPC modeling, this study projects rising incidence and prevalence through 2045, driven by aging and metabolic risk. Targeted, China‐specific prevention and digital health strategies are urgently needed to mitigate future burden.
Junpeng Xiong, Shuwen Chen, Xiaoli Wu, Bingyin Wang, Binquan You, Ronghui Yu   +5 more
wiley   +1 more source

Comparison of First-Line Antihypertensive Drugs by a Randomized Cross-Over Method. A Preliminary Report.

, 1995
Shunichi Kojima, Yuhei Kawano, Yuji Yoshitomi, Morio Kuramochi, Hiroaki Matsuoka, Teruo Omae   +5 more
openalex   +2 more sources

Cardiovascular Biomarkers in Nocturnal Hemodialysis and Their Association With Physical Performance

Hemodialysis International, EarlyView.
ABSTRACT Introduction The cardiovascular biomarkers troponin T, N‐terminal pro‐B‐type natriuretic peptide, and fibroblast growth factor 23 are elevated in hemodialysis patients and associated with an increased cardiovascular mortality risk. Nocturnal hemodialysis improves the fluid status in hemodialysis patients.
Manouk Dam, Laura M. M. de Haan, Tiny Hoekstra, Marc Vervloet, Frans J. van Ittersum, Peter J. M. Weijs, Brigit C. van Jaarsveld   +6 more
wiley   +1 more source

Swiss Quality of Life and Health Care Impact Assessment in a Real‐World Erenumab‐Treated Migraine Population: Results over 2 years

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This prospective, multicenter, noninterventional cohort study evaluated the impact of erenumab on the quality of life and migraine‐related impairment of adult patients with migraine, as well as the drug's tolerability in a real‐world setting over 2 years.
Andreas R. Gantenbein, Christian P. Kamm, Christoph J. Schankin, Chiara Zecca, Dominik Zieglgänsberger, Heiko Pohl, Philippe Ryvlin, Reto Agosti, Dragana Viceic, Catherine Parzini, Monika Kulartz‐Schank, Michael E. Arzt   +11 more
wiley   +1 more source

Genetic alterations in hepatocellular carcinoma after sustained virological response in relation to the molecular characterization of metabolic diseases

Hepatology Research, EarlyView.
Hepatocellular carcinoma (HCC) in the hepatitis C virus (HCV)‐sustained virologic response (SVR) group was associated with alcohol consumption and metabolic diseases and showed significantly lower rates of ARID2 alterations and AXIN1 alterations compared to the HCV‐non‐SVR group, with a mutational profile resembling that of the steatotic liver disease ...
Fukiko Kawai‐Kitahata, Yasuhiro Asahina, Sei Kakinuma, Kento Inada, Tomohiro Mochida, Keiya Watakabe, Tsubasa Nobusawa, Taro Shimizu, Jun Tsuchiya, Masato Miyoshi, Shun Kaneko, Miyako Murakawa, Sayuri Nitta, Mina Nakagawa, Yuko Kinowaki, Daisuke Ban, Shinji Tanaka, Tatsuhiko Anzai, Shinichi Takano, Shinya Maekawa, Nobuyuki Enomoto, Ryuichi Okamoto   +21 more
wiley   +1 more source

Effect of Plasma Zinc, Retinol Binding Protein and Antihypertensive Drugs on Taste Dysfunction on Hemodialysis Patients.

, 1999
Taeko Shimoda, Nagatomo Nakamura, Michiyo Hujinaga   +2 more
openalex   +2 more sources

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development

International Journal of Dermatology, EarlyView.
ABSTRACT Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease, with a rising incidence in the elderly. BP is associated with multiple triggering factors, including drug exposure. However, evidence in this respect is limited, and the underlying immune mechanisms remain unknown.
Belen de Nicolas‐Ruanes, Carlos Fernandez‐Lozano, Patricia Gutierrez‐Canales, Asuncion Ballester‐Martinez, Natalia Rodriguez‐Otero, Javier Martinez‐Botas, Belén de la Hoz Caballer, Ana Andres‐Martin, Emilio Solano‐Solares, Maria Esther Gomez‐Salazar Lopez‐Silanes, Laura Gisella Diaz‐Montalvo, Diana M. Arrebola, Vivian Lizeth Stewart‐Delcid, Emilio Garcia‐Mouronte, Carlos Azcarraga‐Llobet, Emilio Berna‐Rico, Sonia Ortega‐Sanchez, Montserrat Fernandez‐Guarino   +17 more
wiley   +1 more source

Hyperhidrosis: don't sweat it

Internal Medicine Journal, EarlyView.
Abstract Hyperhidrosis is an under‐reported and under‐treated condition that causes significant patient morbidity. Secondary causes require consideration, but the vast majority of cases are idiopathic. The condition is encountered by a range of clinicians, including neurologists, dermatologists and endocrinologists, and it pays to be familiar with the ...
Mitchell J. Lycett, Karl Ng
wiley   +1 more source